Home Cart Sign in  
Chemical Structure| 570406-98-3 Chemical Structure| 570406-98-3

Structure of Avatrombopag
CAS No.: 570406-98-3

Chemical Structure| 570406-98-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Avatrombopag is an orally-active thrombopoietin (TPO) receptor agonist with EC50 of 3.3 nM.

Synonyms: YM477; AKR-501; AS 1670542

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Avatrombopag

CAS No. :570406-98-3
Formula : C29H34Cl2N6O3S2
M.W : 649.65
SMILES Code : O=C(C1CCN(C2=NC=C(C(NC3=NC(C4=CC(Cl)=CS4)=C(N5CCN(C6CCCCC6)CC5)S3)=O)C=C2Cl)CC1)O
Synonyms :
YM477; AKR-501; AS 1670542
MDL No. :MFCD18633249
InChI Key :OFZJKCQENFPZBH-UHFFFAOYSA-N
Pubchem ID :9852519

Safety of Avatrombopag

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H317-H319
Precautionary Statements:P280-P305+P351+P338

Isoform Comparison

Biological Activity

Description
Avatrombopag (AKR-501) is an orally active, nonpeptide thrombopoietin (TPO) receptor agonist with an EC50 of 3.3 nM. It mimics the biological activities of TPO, stimulating platelet production by activating the intracellular signaling system and promoting the generation of platelets and megakaryocytes from hematopoietic precursor cells. Avatrombopag is metabolized by cytochrome P450 (CYP) 2C9 and CYP3A enzymes [1][2][3].

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT04949009 Primary Immune Thrombocytopeni... More >>a Less << UNKNOWN 2025-03-22 Qilu Hospital, Shandong Univer... More >>sity, Jinan, Shandong, China Less <<
NCT05218226 Chemotherapy-induced Thrombocy... More >>topenia|Avatrombopag Less << PHASE2 UNKNOWN 2024-12-31 Chinese Academy of Medical Sci... More >>ence and Blood Disease Hospital, Tianjin, Tianjin, 300020, China Less <<
NCT05823376 Platelet Recovery After Umbili... More >>cal Cord Blood Transplantation Less << RECRUITING 2025-02-28 The First Affiliated Hospital ... More >>of University of Science and Technology of China (Anhui Provincial Hospital), Hefei, Anhui, 230036, China Less <<
NCT01437384 Idiopathic Thrombocytopenic Pu... More >>rpura (ITP) Less << PHASE1 COMPLETED - Celerion, Tempe, Arizona, 8528... More >>3, United States Less <<
NCT03554759 Thrombocytopenia TERMINATED 2019-01-31 Dova Site, Chandler, Arizona, ... More >>85224, United States|Dova Site, Lancaster, California, 93534, United States|Dova Study Site, Los Angeles, California, 90048, United States|Dova Site, Palm Springs, California, 92262, United States|Dova Study Site, Pasadena, California, 91107, United States|Dova Study Site, San Clemente, California, 92673, United States|Dova Study Site, San Diego, California, 92114, United States|Dova Study Site, San Diego, California, 92121, United States|Dova Study Site, Aurora, Colorado, 80045, United States|Dova Study Site, Englewood, Colorado, 80113, United States|Dova Study Site, Gainesville, Florida, 32610, United States|Dova Study Site, Miami, Florida, 33136, United States|Dova Study Site, Atlanta, Georgia, 30309, United States|Dova Study Site, Topeka, Kansas, 66606, United States|Dova Study Site, Louisville, Kentucky, 40202, United States|Dova Study Site, Baltimore, Maryland, 21202, United States|Dova Study Site, Boston, Massachusetts, 02215, United States|Dova Study Site, Burlington, Massachusetts, 01805, United States|Dova Study Site, Worcester, Massachusetts, 01655, United States|Dova Study Site, Ann Arbor, Michigan, 48109, United States|Dova Study Site, Detroit, Michigan, 48239, United States|Dova Site, Jackson, Mississippi, 39216, United States|Dova Study Site, New Brunswick, New Jersey, 08901, United States|Dova Study Site, Bronx, New York, 10467, United States|Dova Study Site, Manhasset, New York, 11030, United States|Dova Study Site, New York, New York, 10016, United States|Dova Study Site, Durham, North Carolina, 27710, United States|Dova Study Site, Cleveland, Ohio, 44016, United States|Dova Study Site, Columbus, Ohio, 43210, United States|Dova Study Site, Flourtown, Pennsylvania, 19031, United States|Dova Site, Philadelphia, Pennsylvania, 19141, United States|Dova Study Site, Pittsburgh, Pennsylvania, 15213, United States|Dova Study Site, Johnson City, Tennessee, 37604, United States|Dova Study Site, Memphis, Tennessee, 38104, United States|Dova Study Site, Union City, Tennessee, 38261, United States|Dova Study Site, Dallas, Texas, 75234, United States|Dova Study Site, Houston, Texas, 77030, United States|Dova Study Site, Charlottesville, Virginia, 22908, United States|Dova Study Site, Richmond, Virginia, 23226, United States|Dova Study SIte, Roanoke, Virginia, 24014, United States|Dova Study Site, Milwaukee, Wisconsin, 53226, United States Less <<
NCT05087459 Thrombocytopenia UNKNOWN 2025-07-22 Zhongshan hospital, Fudan Univ... More >>ersity, Shanghai, China Less <<
NCT04943042 Immune Thrombocytopenia|ITP ACTIVE_NOT_RECRUITING 2025-05-25 Swedish Orphan Biovitrum Resea... More >>rch Site 131, Zagreb, Croatia|Swedish Orphan Biovitrum Research Site 122, Brno, Czechia|Swedish Orphan Biovitrum Research Site 123, Ostrava, Czechia|Swedish Orphan Biovitrum Research Site 121, Praha, Czechia|Swedish Orphan Biovitrum Research Site 124, Praha, Czechia|Swedish Orphan Biovitrum Research Site 125, Praha, Czechia|Swedish Orphan Biovitrum Research Site 108, Aschaffenburg, Germany|Swedish Orphan Biovitrum Research Site 114, Augsburg, Germany|Swedish Orphan Biovitrum Research Site 116, Augsburg, Germany|Swedish Orphan Biovitrum Research Site 103, Bad Homburg, Germany|Swedish Orphan Biovitrum Research Site 106, Berlin, Germany|Swedish Orphan Biovitrum Research Site 113, Dresden, Germany|Swedish Orphan Biovitrum Research Site 102, Frankfurt, Germany|Swedish Orphan Biovitrum Research Site 105, Frankfurt, Germany|Swedish Orphan Biovitrum Research Site 104, Hannover, Germany|Swedish Orphan Biovitrum Research Site 112, Kaiserslautern, Germany|Swedish Orphan Biovitrum Research Site 101, Kassel, Germany|Swedish Orphan Biovitrum Research Site 115, Leipzig, Germany|Swedish Orphan Biovitrum Research Site 109, Schorndorf, Germany|Swedish Orphan Biovitrum Research Site 111, Stolberg, Germany|Swedish Orphan Biovitrum Research Site 509, Bologna, Italy|Swedish Orphan Biovitrum Research Site 504, Catania, Italy|Swedish Orphan Biovitrum Research Site 502, Firenze, Italy|Swedish Orphan Biovitrum Research Site 506, Meldola, Italy|Swedish Orphan Biovitrum Research Site 510, Milano, Italy|Swedish Orphan Biovitrum Research Site 511, Milan, Italy|Swedish Orphan Biovitrum Research Site 503, Roma, Italy|Swedish Orphan Biovitrum Research Site 505, Rome, Italy|Swedish Orphan Biovitrum Research Site 202, Apeldoorn, 7334 DZ, Netherlands|Swedish Orphan Biovitrum Research Site 204, Arnhem, Netherlands|Swedish Orphan Biovitrum Research Site 203, Den Haag, Netherlands|Swedish Orphan Biovitrum Research Site 302, Bergen, Norway|Swedish Orphan Biovitrum Research Site 301, Oslo, Norway|Swedish Orphan Biovitrum Research Site 611, Barcelona, Spain|Swedish Orphan Biovitrum Research Site 609, Burgos, Spain|Swedish Orphan Biovitrum Research Site 610, Granada, Spain|Swedish Orphan Biovitrum Research Site 601, Madrid, Spain|Swedish Orphan Biovitrum Research Site 605, Madrid, Spain|Swedish Orphan Biovitrum Research Site 607, Murcia, Spain|Swedish Orphan Biovitrum Research Site 606, Oviedo, Spain|Swedish Orphan Biovitrum Research Site 608, Palma De Mallorca, Spain|Swedish Orphan Biovitrum Research Site 602, Salamanca, Spain|Swedish Orphan Biovitrum Research Site 604, Sevilla, Spain|Swedish Orphan Biovitrum Research Site 603, Vigo, Spain|Swedish Orphan Biovitrum Research Site 802, Basel, Switzerland|Swedish Orphan Biovitrum Research Site 801, Lausanne, Switzerland|Swedish Orphan Biovitrum Research Site 709, Edinburgh, Scotland, United Kingdom|Swedish Orphan Biovitrum Research Site 708, Glasgow, Scotland, United Kingdom|Swedish Orphan Biovitrum Research Site 701, Bristol, United Kingdom|Swedish Orphan Biovitrum Research Site 704, Leicester, United Kingdom|Swedish Orphan Biovitrum Research Site 707, London, United Kingdom|Swedish Orphan Biovitrum Research Site 710, London, United Kingdom|Swedish Orphan Biovitrum Research Site 705, Newcastle, United Kingdom|Swedish Orphan Biovitrum Research Site 702, Nottingham, United Kingdom|Swedish Orphan Biovitrum Research Site 703, Oxford, United Kingdom Less <<
NCT04609891 Thrombocytopenia COMPLETED 2021-05-16 Anhui Provincial Cancer Hospit... More >>al, Hefei, Anhui, 230000, China Less <<
NCT04437953 Thrombocytopenia|Cancer|Liver ... More >>Diseases Less << PHASE2 WITHDRAWN 2020-12-03 -
NCT04993885 Immune Thrombocytopenia|Autoan... More >>tibodies|Evan Syndrome|Connective Tissue Diseases Less << PHASE2 RECRUITING 2024-09-30 Institute of Hematology & Bloo... More >>d Diseases Hospital, Tianjin, Tianjin, 300020, China Less <<
NCT06281327 Immune Thrombocytopenia|Treatm... More >>ent Less << PHASE2 RECRUITING 2025-12-25 Institute of Hematology and Bl... More >>ood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China Less <<
NCT05433922 Severe Aplastic Anemia UNKNOWN 2024-12-31 Institute of Hematology & Bloo... More >>d Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, Tianjin, 300020, China Less <<
NCT06001567 Thrombocytopenia|Hepatocellula... More >>r Carcinoma Less << PHASE2 RECRUITING 2024-08-13 The Second Affiliated Hospital... More >> of Guangzhou Medical University, Guangzhou, Guangdong, 510260, China Less <<
NCT04312789 Platelet Disorder PHASE2 WITHDRAWN 2022-12-31 -
NCT04896528 Thrombocytopenia|Avatrombopag PHASE2 UNKNOWN 2021-12-31 Peking Union Medical College H... More >>ospital, Beijing, Beijing, 100730, China Less <<
NCT04931849 Thrombocytopenia EARLY_PHASE1 WITHDRAWN 2024-07-18 University of Rochester Medica... More >>l Center, Rochester, New York, 14642, United States Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.54mL

0.31mL

0.15mL

7.70mL

1.54mL

0.77mL

15.39mL

3.08mL

1.54mL

References

 

Historical Records

Categories